🎉 M&A multiples are live!
Check it out!

China Resources Sanjiu Valuation Multiples

Discover revenue and EBITDA valuation multiples for China Resources Sanjiu and similar public comparables like Julphar, Galapagos, and Pharming.

China Resources Sanjiu Overview

About China Resources Sanjiu

China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company operates through three primary segments. The Pharmaceutical Industry segment focuses on manufacturing consumer health (CHC) products, dietary supplements, traditional Chinese medicine health items, and prescription medications. The Printing and Packaging segment handles the design, printing, and packaging of various materials. The Pharmaceuticals, equipment, wholesale, and retail industry segment involves the distribution and sale of pharmaceuticals and medical devices. Products are mainly marketed under the 999 brand, with operations spanning both domestic and international markets.


Founded

1999

HQ

China
Employees

20.0K+

Website

999.com.cn

Financials

LTM Revenue $4.2B

LTM EBITDA $797M

EV

$6.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

China Resources Sanjiu Financials

As of September 2025, China Resources Sanjiu reported last 12-month revenue of $4.2B and EBITDA of $797M.

In the same period, China Resources Sanjiu generated $2.3B in LTM gross profit and $489M in net income.

See China Resources Sanjiu valuation multiples based on analyst estimates

China Resources Sanjiu P&L

In the most recent fiscal year, China Resources Sanjiu reported revenue of $3.9B and EBITDA of $772M.

China Resources Sanjiu expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See China Resources Sanjiu valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $4.2B XXX $3.9B XXX XXX XXX
Gross Profit $2.3B XXX $2.0B XXX XXX XXX
Gross Margin 54% XXX 52% XXX XXX XXX
EBITDA $797M XXX $772M XXX XXX XXX
EBITDA Margin 19% XXX 20% XXX XXX XXX
EBIT $676M XXX $650M XXX XXX XXX
EBIT Margin 16% XXX 17% XXX XXX XXX
Net Profit $489M XXX $472M XXX XXX XXX
Net Margin 12% XXX 12% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

China Resources Sanjiu Stock Performance

China Resources Sanjiu has current market cap of CNY 48.4B (or $6.8B), and EV of CNY 44.8B (or $6.3B).

Market Cap Evolution

China Resources Sanjiu Stock Data

As of October 17, 2025, China Resources Sanjiu's stock price is CNY 29 (or $4).

See China Resources Sanjiu trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$6.3B $6.8B XXX XXX XXX XXX $0.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

China Resources Sanjiu Valuation Multiples

China Resources Sanjiu's trades at 1.6x EV/Revenue multiple, and 8.1x EV/EBITDA.

See valuation multiples for China Resources Sanjiu and 15K+ public comps

China Resources Sanjiu Financial Valuation Multiples

As of October 17, 2025, China Resources Sanjiu has market cap of $6.8B and EV of $6.3B.

Equity research analysts estimate China Resources Sanjiu's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

China Resources Sanjiu has a P/E ratio of 13.9x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $6.8B XXX $6.8B XXX XXX XXX
EV (current) $6.3B XXX $6.3B XXX XXX XXX
EV/Revenue 1.5x XXX 1.6x XXX XXX XXX
EV/EBITDA 7.9x XXX 8.1x XXX XXX XXX
EV/EBIT 9.3x XXX 9.7x XXX XXX XXX
EV/Gross Profit 2.8x XXX n/a XXX XXX XXX
P/E 13.9x XXX 14.4x XXX XXX XXX
EV/FCF 12.3x XXX 12.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get China Resources Sanjiu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

China Resources Sanjiu Margins & Growth Rates

China Resources Sanjiu's last 12 month revenue growth is 10%

China Resources Sanjiu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

China Resources Sanjiu's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

China Resources Sanjiu's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for China Resources Sanjiu and other 15K+ public comps

China Resources Sanjiu Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 10% XXX 10% XXX XXX XXX
EBITDA Margin 19% XXX 20% XXX XXX XXX
EBITDA Growth 11% XXX 12% XXX XXX XXX
Rule of 40 28% XXX 30% XXX XXX XXX
Bessemer Rule of X XXX XXX 43% XXX XXX XXX
Revenue per Employee XXX XXX $0.2M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 21% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 3% XXX XXX XXX
Opex to Revenue XXX XXX 35% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

China Resources Sanjiu Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

China Resources Sanjiu M&A and Investment Activity

China Resources Sanjiu acquired  XXX companies to date.

Last acquisition by China Resources Sanjiu was  XXXXXXXX, XXXXX XXXXX XXXXXX . China Resources Sanjiu acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by China Resources Sanjiu

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About China Resources Sanjiu

When was China Resources Sanjiu founded? China Resources Sanjiu was founded in 1999.
Where is China Resources Sanjiu headquartered? China Resources Sanjiu is headquartered in China.
How many employees does China Resources Sanjiu have? As of today, China Resources Sanjiu has 20.0K+ employees.
Is China Resources Sanjiu publicy listed? Yes, China Resources Sanjiu is a public company listed on SHE.
What is the stock symbol of China Resources Sanjiu? China Resources Sanjiu trades under 000999 ticker.
When did China Resources Sanjiu go public? China Resources Sanjiu went public in 2000.
Who are competitors of China Resources Sanjiu? Similar companies to China Resources Sanjiu include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of China Resources Sanjiu? China Resources Sanjiu's current market cap is $6.8B
What is the current revenue of China Resources Sanjiu? China Resources Sanjiu's last 12 months revenue is $4.2B.
What is the current revenue growth of China Resources Sanjiu? China Resources Sanjiu revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of China Resources Sanjiu? Current revenue multiple of China Resources Sanjiu is 1.5x.
Is China Resources Sanjiu profitable? Yes, China Resources Sanjiu is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of China Resources Sanjiu? China Resources Sanjiu's last 12 months EBITDA is $797M.
What is China Resources Sanjiu's EBITDA margin? China Resources Sanjiu's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of China Resources Sanjiu? Current EBITDA multiple of China Resources Sanjiu is 7.9x.
What is the current FCF of China Resources Sanjiu? China Resources Sanjiu's last 12 months FCF is $511M.
What is China Resources Sanjiu's FCF margin? China Resources Sanjiu's last 12 months FCF margin is 12%.
What is the current EV/FCF multiple of China Resources Sanjiu? Current FCF multiple of China Resources Sanjiu is 12.3x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.